Subscribe to RSS Feed
Medicines-Diabetes Treatment-InstituteOfEPM-Boiron-EndoPharm-NovoNordisk-Valenta-Zentiva-Lilly-Shering-Plau-Sintez-Lannacher-Medisorb-Ellara-Kamelia-Vifor-Italfarmaco-Falk Pharma-Tyumen CPP-SUNpharma-UPSA-Vetprom-Shreya-Dompe-Hyperion-Hexal-Avexima-GeneScience Pharmaceuticals-Фармстандарт-Лексредства ОАО
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-InstituteOfEPM-Boiron-EndoPharm-NovoNordisk-Valenta-Zentiva-Lilly-Shering-Plau-Sintez-Lannacher-Medisorb-Ellara-Kamelia-Vifor-Italfarmaco-Falk Pharma-Tyumen CPP-SUNpharma-UPSA-Vetprom-Shreya-Dompe-Hyperion-Hexal-Avexima-GeneScience Pharmaceuticals-Фармстандарт-Лексредства ОАО
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
InstituteOfEPM
Boiron
EndoPharm
NovoNordisk
Valenta
Zentiva
Lilly
Shering-Plau
Sintez
Lannacher
Medisorb
Ellara
Kamelia
Vifor
Italfarmaco
Falk Pharma
Tyumen CPP
SUNpharma
UPSA
Vetprom
Shreya
Dompe
Hyperion
Hexal
Avexima
GeneScience Pharmaceuticals
OTCPharm JSC
- The purpose of the medication
- Manufacturer
